Occidental Petroleum Corp. (0KAK)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 62.82 |
|---|---|
| 52-week range | 38.80 – 68.38 |
| Return, 1 month / 3 months | +9.4% / +8.4% |
| Return, 1 year / 3 years | +54.1% / +6.2% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -27.3% |
| Average daily value traded | 1.20M USD |
| Dividend yield | 0.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Occidental Petroleum is an energy company based in Houston, Texas, that explores for and produces crude oil, natural gas liquids and natural gas, with major operations in the Permian Basin of the United States and in other regions. Through its chemicals business it makes basic industrial chemicals such as chlorine and caustic soda, and it also runs midstream and marketing operations that gather, process and transport hydrocarbons for industrial customers and energy markets.
The shares are listed on the London Exchange in UK under the code 0KAK, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Occidental Petroleum Corp. (0KAK) trades on the London Exchange in UK. It last closed at USD 62.82 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,011 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.1% and over the last three months it rose 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.5% | ||
| From 52-week high | -5.2% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.4% | ||
| 6-month return | 10.8% | ||
| 12-month return, skipping the last month | 40.9% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.3% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.20M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +9.4% |
| 3 months | +8.4% |
| 6 months | +10.8% |
| 1 year | +54.1% |
| 3 years | +6.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 59.65 / 55.34 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Dec 2025 | USD 0.2400 |
| 10 Sep 2025 | USD 0.2400 |
| 9 Jun 2025 | USD 0.2400 |
| 7 Mar 2025 | USD 0.2400 |
| 10 Dec 2024 | USD 0.2200 |
| 10 Sep 2024 | USD 0.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.